Compound ID | 820
Synonym(s): Rx-01 series: Rx-01_667
Class: Oxazolidinone
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | 50S ribosomal subunit inhibitor; this series generally showed lower MICS against S. aureus and enterococcal isolates |
Description: | Lawrence L, Sutcliffe J. In vitro activity of designer oxazolidinones against respiratory pathogens. 45th-Intersci-Conf-Antimicrob-Agents-Chemother 2005;198. |
Institute where first reported: | Rib-X Pharmaceuticals (Melinta Therapeutics, USA) |
Year first mentioned: | 2005 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Chemical structure(s): | |
Canonical SMILES: | CC(=O)NC[C@H]1CN(C2=CC=C(C3=CC=C(C=C3)CNCC4=NNN=C4)C(=C2)F)C(=O)O1 |
Isomeric SMILES: | CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)CNCC4=NNN=C4)F |
InChI: | InChI=1S/C22H23FN6O3/c1-14(30)25-12-19-13-29(22(31)32-19)18-6-7-20(21(23)8-18)16-4-2-15(3-5-16)9-24-10-17-11-26-28-27-17/h2-8,11,19,24H,9-10,12-13H2,1H3,(H,25,30)(H,26,27,28)/t19-/m0/s1 |
InChI Key: | BTTNOGHPGJANSW-IBGZPJMESA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/11224409 |
External links: | |
Guide to Pharmacology: | radezolid |